Skip to content

Long-Term Benefits of Eccentric Cycling Exercise in Patients With Type 2 Diabetes Mellitus

Exploring Long-Term Benefits of Eccentric Cycling Exercise on Physiological Responses, Exercise Capacity, and Quality of Life in Patients With Type 2 Diabetes Mellitus

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07109102
Enrollment
30
Registered
2025-08-07
Start date
2025-08-31
Completion date
2026-08-31
Last updated
2025-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus (T2DM)

Keywords

Eccentric cycling, eccentric exercise, exercise capacity, quality of life, physiological responses, Type 2 diabetes mellitus

Brief summary

The goal of this interventional study is to evaluate the long-term benefits of eccentric (ECC) cycling exercise on physiological responses, exercise capacity, and quality of life (QoL) in patients with type 2 diabetes mellitus (T2DM). The main questions it aims to answer are: * What are the effects of ECC cycling compared to concentric (CON) cycling on physiological responses, exercise capacity, and QoL in patients with T2DM? * What are the differential effects of moderate- and high-intensity ECC cycling compared to CON cycling on physiological responses, exercise capacity, and QoL in patients with T2DM? Researchers will compare moderate- and high-intensity ECC cycling to CON cycling (conventional cycling) to see if ECC cycling can be a viable alternative or complement to existing exercise protocols for managing T2DM. Participants will: * Undergo pre-, mid-, and post-intervention assessment * Perform either moderate- or high-intensity ECC cycling or moderate intensity CON cycling according to group randomisation by the researcher. * Start with two familiarisation sessions prior to the actual cycling training. * Perform cycling exercise twice per week for 10 weeks.

Interventions

OTHERModerate-intensity eccentric cycling

* This group will perform eccentric cycling exercise twice per week for ten weeks using the Cyclus2 standard eccentric ergometer. * The intensity will start at 60% of the peak power output (PPO) of the incremental concentric cycling test. * The intensity will progressively increase by 5% of PPO every 2 weeks (60%-80% PPO).

OTHERHigh-intensity eccentric cycling

* This group will perform eccentric cycling exercise twice per week for ten weeks using the Cyclus2 standard eccentric ergometer. * The intensity will start at 80% of the peak power output (PPO) of the incremental concentric cycling test. * The intensity will progressively increase by 5% of PPO every 2 weeks (80%-100% PPO).

OTHERModerate-intensity concentric cycling

* This group will perform concentric cycling exercise twice per week for ten weeks using the Lode Excalibur sport ergometer. * The intensity will start at 60% of the peak power output (PPO) of the incremental concentric cycling test. * The intensity will progressively increase by 5% of PPO every 2 weeks (60%-80% PPO).

Sponsors

Universiti Sains Malaysia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

This study is an open-label, single-centre, parallel-group, three-arm, randomised controlled study.

Eligibility

Sex/Gender
MALE
Age
30 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Male diagnosed with T2DM * Age 30 - 60 years old * Height ≥155cm (To ensure proper ergonomics, comfort and safety during cycling) * HbA1C level between 6-8% * No resistance exercise for ≤ 3 months before participating in the current study. * Physical inactivity (moderate to vigorous exercise ≤60 minutes weekly based on International Physical Activity Questionnaires-Short Form (IPAQ-SF))

Exclusion criteria

* Acute illness or any foot ulcer, diabetic ulcer, retinopathy, kidney, musculoskeletal, cardiovascular, or neurological disorder that could impair exercise performance or pose a risk to participants during exercise. * Insulin injection

Design outcomes

Primary

MeasureTime frameDescription
Glycated haemoglobin (HbA1C)Baseline and post-intervention at 10 weeks
Lipid profileBaseline and post-intervention at 10 weeks
Maximal voluntary contraction (MVC)Baseline, mid-intervention (6 weeks), and post-intervention (10 weeks).isometric quadriceps peak torque (QPT) and isokinetic QPT
Exercise capacityBaseline, mid-intervention (6 weeks), and post-intervention (10 weeks)6-minute walk test (6-MWT)
13-item Revised Version of Diabetes Quality of Life (RV-DQOL13)Baseline, mid-intervention (6 weeks), and post-intervention (10 weeks)Scores range from 13 to 65, with higher scores reflecting reduced quality of life
Short Form-12 (SF-12) health surveyBaseline, mid-intervention (6 weeks), and post-intervention (10 weeks)Scoring ranges from 0 to 100, with higher scores indicating better physical and mental health.

Secondary

MeasureTime frameDescription
Body mass index (BMI)Baseline, mid-intervention (6 weeks), and post-intervention (10 weeks)BMI is calculated as weight (kg) divided by height (m²).
Electromyography (EMG) for muscle activity assessmentBaseline, mid-intervention (6 weeks), and post-intervention (10 weeks)To assess quadriceps muscle activity (rectus femoris, vastus medialis oblique, and vastus lateralis) during maximal voluntary contraction.
The short version of the physical activity enjoyment scale (PACES-S)Mid-intervention (6 weeks), and post-intervention (10 weeks)Exercise enjoyment will be assessed using a five-point Likert scale (1 = strongly disagree to 5 = strongly agree), with total scores ranging from 4 to 20; higher scores indicate greater enjoyment.
Body circumferenceBaseline, mid-intervention (6 weeks), and post-intervention (10 weeks)Measure the waist circumference (WC), hip circumference (HC), and thigh circumference (TC) in centimetres with a measuring tape.
Blood pressureBaseline and up to 10 weekssystolic blood pressure (SBP), diastolic blood pressure (DBP),
Heart rateBaseline and up to 10 weeks
Borg Category-Ratio scale (Borg CR-10)Every cycling training session from week 1 to week 10The scale ranges from 0 (nothing at all) to 10 (extremely strong) to represent the participants' subjective feelings of breathlessness and leg fatigue.
Body weightBaseline, mid-intervention (6 weeks), and post-intervention (10 weeks)Body weight in kilograms (kg)
HeightBaseline, mid-intervention (6 weeks), and post-intervention (10 weeks)Height in centimeters (cm)

Countries

Malaysia

Contacts

Primary ContactSyamimi Shamsuddin
syamimi.s@usm.my+6045622024

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026